Literature DB >> 8545649

Bupivicaine arthrography of the post-arthroplasty hip.

E M Braunstein1, E Cardinal, K A Buckwalter, W Capello.   

Abstract

Addition of bupivicaine, a medium-length-acting local anesthetic, to the contrast material in arthrography of total hip prostheses provides reliable information as to whether the source of pain is intracapsular or extracapsular. In 12 surgically proven cases, complete relief of pain after bupivicaine injection correctly identified an intracapsular source of pain in 10, with only 1 false-positive and 1 false-negative. These results compare favorably with the results of the contrast arthrograms in these patients in localizing the pain even if a specific diagnosis could not be reached. Bupivicaine as an adjunct to contrast material during arthrography provides additional information useful in management decisions regarding the necessity of revision arthroplasty.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545649     DOI: 10.1007/bf00202150

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  4 in total

1.  The lateral approach for hip arthrography.

Authors:  R F Kilcoyne; P Kaplan
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

2.  Contrast and nuclear arthrography in loosening of the uncemented hip prosthesis.

Authors:  J S Swan; E M Braunstein; H N Wellman; W Capello
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

3.  Cervical analgesic facet joint arthrography.

Authors:  B Hove; C Gyldensted
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

4.  The value of bupivicaine hip injection in the differentiation of coxarthrosis from lower extremity neuropathy.

Authors:  J B Kleiner; R P Thorne; J G Curd
Journal:  J Rheumatol       Date:  1991-03       Impact factor: 4.666

  4 in total
  1 in total

1.  [Approach to painful hip resurfacing].

Authors:  L Gerdesmeyer; H Gollwitzer; P Diehl; M Fuerst; M Schmitt-Sody
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.